Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

The effects of oral iron supplementation on the progression of anemia and renal dysfunction in patients with chronic kidney disease.

Kim SM, Lee CH, Oh YK, Joo KW, Kim YS, Kim S, Lim CS.

Clin Nephrol. 2011 May;75(5):472-9.

PMID:
21543028
2.

Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis.

Rozen-Zvi B, Gafter-Gvili A, Paul M, Leibovici L, Shpilberg O, Gafter U.

Am J Kidney Dis. 2008 Nov;52(5):897-906. doi: 10.1053/j.ajkd.2008.05.033. Review.

PMID:
18845368
3.

Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?

Macdougall IC.

Curr Med Res Opin. 2010 Feb;26(2):473-82. doi: 10.1185/03007990903512461. Review.

PMID:
20014980
4.

2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.

Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.

Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x.

PMID:
20609178
5.

Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study.

Perlman RL, Finkelstein FO, Liu L, Roys E, Kiser M, Eisele G, Burrows-Hudson S, Messana JM, Levin N, Rajagopalan S, Port FK, Wolfe RA, Saran R.

Am J Kidney Dis. 2005 Apr;45(4):658-66.

PMID:
15806468
6.

Bone marrow iron, iron indices, and the response to intravenous iron in patients with non-dialysis-dependent CKD.

Stancu S, Stanciu A, Zugravu A, Bârsan L, Dumitru D, Lipan M, Mircescu G.

Am J Kidney Dis. 2010 Apr;55(4):639-47. doi: 10.1053/j.ajkd.2009.10.043. Erratum in: Am J Kidney Dis. 2010 Nov;5(11):2137-8.

PMID:
20079959
7.

Epoetin-beta (Recormon-Roche) in the treatment of renal anemia in patients with chronic renal failure.

Tilkian EE, Tzekov VD, Pandeva SM, Kumchev EP, Nikolov DG, Dimitrakov JD, Dimitrakov DD.

Folia Med (Plovdiv). 2000;42(3):11-5.

PMID:
11347329
8.

Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the Veterans Health Administration.

Lawler EV, Gagnon DR, Fink J, Seliger S, Fonda J, Do TP, Gaziano JM, Bradbury BD.

Nephrol Dial Transplant. 2010 Jul;25(7):2237-44. doi: 10.1093/ndt/gfp758.

9.

Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.

Sturm G, Kollerits B, Neyer U, Ritz E, Kronenberg F; MMKD Study Group..

Exp Gerontol. 2008 Apr;43(4):347-52. doi: 10.1016/j.exger.2008.01.006.

PMID:
18294794
10.

[What are the aims and targets of renal anemia therapy?].

Eckardt KU.

Dtsch Med Wochenschr. 2007 Sep;132(36):1837-41. Review. German. No abstract available.

PMID:
17726657
11.

Considerations for optimal iron use for anemia due to chronic kidney disease.

Hudson JQ, Comstock TJ.

Clin Ther. 2001 Oct;23(10):1637-71. Review.

PMID:
11726002
12.

[IV iron or oral iron in anaemic patient with CKD].

Frimat L, Thilly N, Boini S.

Nephrol Ther. 2006 Nov;2 Suppl 5:S347-9. French.

PMID:
17373282
13.

Evaluation of epoetin supplemented with oral iron in patients with solid malignancies and chronic anemia not receiving anticancer treatment.

Mystakidou K, Kalaidopoulou O, Katsouda E, Parpa E, Kouskouni E, Chondros C, Tsiatas ML, Vlahos L.

Anticancer Res. 2005 Sep-Oct;25(5):3495-500.

14.

Influence of ketoanalogs supplementation on the progression in chronic kidney disease patients who had training on low-protein diet.

Chang JH, Kim DK, Park JT, Kang EW, Yoo TH, Kim BS, Choi KH, Lee HY, Han DS, Shin SK.

Nephrology (Carlton). 2009 Dec;14(8):750-7. doi: 10.1111/j.1440-1797.2009.01115.x.

PMID:
20025684
15.

Iron supplementation in renal anemia.

Fishbane S.

Semin Nephrol. 2006 Jul;26(4):319-24. Review.

PMID:
16949471
16.

[Administration of iron-containing drugs in non-dialyzed patients with chronic kidney disease].

Grzegorzewska AE.

Pol Arch Med Wewn. 2007 Apr;117(4):52-7. Review. Polish.

17.

Influence of the 6-month anemia therapy with erythropoietin on renal function and some hemodynamic parameters in predialysis patients.

Tomczak-Watras W, Strózecki P, Zuchora Z, Szefer J, Manitius J.

Pol Arch Med Wewn. 2009 Jan-Feb;119(1-2):45-51.

18.

Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease.

Thorp ML, Johnson ES, Yang X, Petrik AF, Platt R, Smith DH.

Nephrology (Carlton). 2009 Apr;14(2):240-6. doi: 10.1111/j.1440-1797.2008.01065.x.

PMID:
19207866
19.

Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.

Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F; MMKD Study Group., Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P.

J Am Soc Nephrol. 2007 Sep;18(9):2600-8.

20.

Iron supplementation for acute blood loss anemia after coronary artery bypass surgery: a randomized, placebo-controlled study.

Crosby L, Palarski VA, Cottington E, Cmolik B.

Heart Lung. 1994 Nov-Dec;23(6):493-9.

PMID:
7852064
Items per page

Supplemental Content

Support Center